OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery
Slimane Zerdoud, Anne‐Laure Giraudet, Sophie Leboulleux, et al.
Annales d Endocrinologie (2017) Vol. 78, Iss. 3, pp. 162-175
Closed Access | Times Cited: 48
Slimane Zerdoud, Anne‐Laure Giraudet, Sophie Leboulleux, et al.
Annales d Endocrinologie (2017) Vol. 78, Iss. 3, pp. 162-175
Closed Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Carbon adsorbents for the uptake of radioactive iodine from contaminated water effluents: A systematic review
Makhabbat Kunarbekova, Rosa Busquets, Ye. Sailaukhanuly, et al.
Journal of Water Process Engineering (2024) Vol. 67, pp. 106174-106174
Closed Access | Times Cited: 11
Makhabbat Kunarbekova, Rosa Busquets, Ye. Sailaukhanuly, et al.
Journal of Water Process Engineering (2024) Vol. 67, pp. 106174-106174
Closed Access | Times Cited: 11
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system
Nathalie Chéreau, Taofik Oyekunle, Alan Zambeli-Ljepović, et al.
British journal of surgery (2019) Vol. 106, Iss. 7, pp. 889-897
Open Access | Times Cited: 28
Nathalie Chéreau, Taofik Oyekunle, Alan Zambeli-Ljepović, et al.
British journal of surgery (2019) Vol. 106, Iss. 7, pp. 889-897
Open Access | Times Cited: 28
The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells
Mathilde Bauriaud-Mallet, Lavinia Vija-Racaru, S. Brillouet, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 192, pp. 105390-105390
Open Access | Times Cited: 26
Mathilde Bauriaud-Mallet, Lavinia Vija-Racaru, S. Brillouet, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 192, pp. 105390-105390
Open Access | Times Cited: 26
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine
Matthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Nuklearmedizin - NuclearMedicine (2022) Vol. 61, Iss. 02, pp. 87-96
Open Access | Times Cited: 15
Matthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Nuklearmedizin - NuclearMedicine (2022) Vol. 61, Iss. 02, pp. 87-96
Open Access | Times Cited: 15
Tumor size and presence of metastases in differentiated thyroid cancer: comparing cohorts from two countries
Evert F.S. van Velsen, Robin P. Peeters, Merel T Stegenga, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 6, pp. 519-525
Open Access | Times Cited: 7
Evert F.S. van Velsen, Robin P. Peeters, Merel T Stegenga, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 6, pp. 519-525
Open Access | Times Cited: 7
Thyroid cancer radiotheragnostics: the case for activity adjusted 131I therapy
Anca M. Avram, Yuni K. Dewaraja
Clinical and Translational Imaging (2018) Vol. 6, Iss. 5, pp. 335-346
Open Access | Times Cited: 22
Anca M. Avram, Yuni K. Dewaraja
Clinical and Translational Imaging (2018) Vol. 6, Iss. 5, pp. 335-346
Open Access | Times Cited: 22
A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
Matthias Schmidt, Rainer Görges, Alexander Drzezga, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 8, pp. 1195-1201
Open Access | Times Cited: 21
Matthias Schmidt, Rainer Görges, Alexander Drzezga, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 8, pp. 1195-1201
Open Access | Times Cited: 21
Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Journal of Endocrinological Investigation (2018) Vol. 42, Iss. 6, pp. 687-692
Closed Access | Times Cited: 20
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Journal of Endocrinological Investigation (2018) Vol. 42, Iss. 6, pp. 687-692
Closed Access | Times Cited: 20
Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer
Evert F.S. van Velsen, Robin P. Peeters, Merel T Stegenga, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e267-e274
Open Access | Times Cited: 10
Evert F.S. van Velsen, Robin P. Peeters, Merel T Stegenga, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e267-e274
Open Access | Times Cited: 10
The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases
Mengmeng Li, Filip Meheus, Stéphanie Polazzi, et al.
Value in Health (2023) Vol. 26, Iss. 8, pp. 1175-1182
Open Access | Times Cited: 6
Mengmeng Li, Filip Meheus, Stéphanie Polazzi, et al.
Value in Health (2023) Vol. 26, Iss. 8, pp. 1175-1182
Open Access | Times Cited: 6
NIFT-P: Are they indolent tumors? Results of a multi-institutional study
Nathalie Chéreau, Tristan Greilsamer, Éric Mirallié, et al.
Surgery (2018) Vol. 165, Iss. 1, pp. 12-16
Closed Access | Times Cited: 18
Nathalie Chéreau, Tristan Greilsamer, Éric Mirallié, et al.
Surgery (2018) Vol. 165, Iss. 1, pp. 12-16
Closed Access | Times Cited: 18
High-dose radioactive iodine therapy is associated with decreased risk of recurrence in high-risk papillary thyroid cancer
Katherine D. Gray, Sahar Bannani, C. Caillard, et al.
Surgery (2018) Vol. 165, Iss. 1, pp. 37-43
Closed Access | Times Cited: 17
Katherine D. Gray, Sahar Bannani, C. Caillard, et al.
Surgery (2018) Vol. 165, Iss. 1, pp. 37-43
Closed Access | Times Cited: 17
Current practice in intermediate risk differentiated thyroid cancer – a review
Rosália do Prado Padovani, F. Duarte, Camila Nascimento
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 95-108
Closed Access | Times Cited: 5
Rosália do Prado Padovani, F. Duarte, Camila Nascimento
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 95-108
Closed Access | Times Cited: 5
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 4, pp. 1020-1028
Open Access | Times Cited: 16
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 4, pp. 1020-1028
Open Access | Times Cited: 16
Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas
Lucie Boursier, Isabelle Clerc Urmes, Julie Garon, et al.
Annales d Endocrinologie (2020) Vol. 81, Iss. 1, pp. 28-33
Open Access | Times Cited: 13
Lucie Boursier, Isabelle Clerc Urmes, Julie Garon, et al.
Annales d Endocrinologie (2020) Vol. 81, Iss. 1, pp. 28-33
Open Access | Times Cited: 13
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR
Christelle de la Fouchardière, Yann Godbert, Cécile Dalban, et al.
European Journal of Cancer (2021) Vol. 157, pp. 153-164
Open Access | Times Cited: 11
Christelle de la Fouchardière, Yann Godbert, Cécile Dalban, et al.
European Journal of Cancer (2021) Vol. 157, pp. 153-164
Open Access | Times Cited: 11
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population
Nathalie Chéreau, Etienne Dauzier, G. Godiris-Petit, et al.
Langenbeck s Archives of Surgery (2018) Vol. 403, Iss. 3, pp. 325-332
Closed Access | Times Cited: 11
Nathalie Chéreau, Etienne Dauzier, G. Godiris-Petit, et al.
Langenbeck s Archives of Surgery (2018) Vol. 403, Iss. 3, pp. 325-332
Closed Access | Times Cited: 11
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
Robin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Journal of Nuclear Medicine (2018) Vol. 60, Iss. 5, pp. 631-637
Open Access | Times Cited: 11
Robin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Journal of Nuclear Medicine (2018) Vol. 60, Iss. 5, pp. 631-637
Open Access | Times Cited: 11
Prognostic and predictive value of nuclear imaging in endocrine oncology
Giorgio Treglia, B. Goichot, Luca Giovanella, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Giorgio Treglia, B. Goichot, Luca Giovanella, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: a monoinstitutional comparative study
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Endocrine (2019) Vol. 68, Iss. 1, pp. 144-150
Closed Access | Times Cited: 9
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Endocrine (2019) Vol. 68, Iss. 1, pp. 144-150
Closed Access | Times Cited: 9
Definition of the Response to Initial Therapy with Radioiodine in Patients with Differentiated Thyroid Carcinoma: Basal or Stimulated Thyroglobulin?
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Hormone and Metabolic Research (2019) Vol. 51, Iss. 10, pp. 634-638
Open Access | Times Cited: 8
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Hormone and Metabolic Research (2019) Vol. 51, Iss. 10, pp. 634-638
Open Access | Times Cited: 8
Implications and Practical Applications of the Chemical Speciation of Iodine in the Biological Context
Astrid N. Espino‐Vázquez, Flor C. Rojas-Castro, Liria Mitzuko Fajardo-Yamamoto
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 377-414
Open Access | Times Cited: 5
Astrid N. Espino‐Vázquez, Flor C. Rojas-Castro, Liria Mitzuko Fajardo-Yamamoto
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 377-414
Open Access | Times Cited: 5
Can patients with papillary thyroid carcinoma and low postoperative thyroglobulin in the presence of clinically apparent lymph node metastases (cN1) be spared from radioiodine?
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Endocrine (2020) Vol. 70, Iss. 3, pp. 552-557
Closed Access | Times Cited: 6
Pedro Weslley Rosário, Gabriela Franco Mourão, Maria Regina Calsolari
Endocrine (2020) Vol. 70, Iss. 3, pp. 552-557
Closed Access | Times Cited: 6
Predictive value of systemic inflammatory markers for recurrence of papillary thyroid cancer
Guoqiang Wang, Ya‐Hui Ma, Yixiang Liu, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 5, pp. 743-748
Closed Access | Times Cited: 2
Guoqiang Wang, Ya‐Hui Ma, Yixiang Liu, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 5, pp. 743-748
Closed Access | Times Cited: 2
